We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

283 hedge funds and large institutions have $2.86B invested in Amedisys in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 87 increasing their positions, 114 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less first-time investments, than exits

New positions opened: 33 | Existing positions closed: 36

1% less funds holding

Funds holding: 287 → 283 (-4)

2.42% less ownership

Funds ownership: 97.34% → 94.92% (-2.4%)

5% less capital invested

Capital invested by funds: $3.02B → $2.86B (-$162M)

15% less funds holding in top 10

Funds holding in top 10: 13 → 11 (-2)

24% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 114

84% less call options, than puts

Call options by funds: $12.8M | Put options by funds: $81.8M

Holders
283
Holders Change
-4
Holders Change %
-1.39%
% of All Funds
4.08%
Holding in Top 10
11
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-15.38%
% of All Funds
0.16%
New
33
Increased
87
Reduced
114
Closed
36
Calls
$12.8M
Puts
$81.8M
Net Calls
-$68.9M
Net Calls Change
+$1.19M

Top Buyers

1
FCM
Farallon Capital Management
California
+$30.2M
2
Bank of America
Bank of America
North Carolina
+$26.6M
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$23.1M
4
LP
LMR Partners
United Kingdom
+$16.8M
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
+$13.3M

Top Sellers

1
VNIM
Vaughan Nelson Investment Management
Texas
-$27.2M
2
PWAM
Park West Asset Management
California
-$26.2M
3
Morgan Stanley
Morgan Stanley
New York
-$24.8M
4
RIM
Ranger Investment Management
Texas
-$18.9M
5
Deutsche Bank
Deutsche Bank
Germany
-$18.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
VI
301
Vestcor Inc
New Brunswick, Canada
– -$614K -6,459 Closed
GCM
302
Greenland Capital Management
New York
– -$475K -5,000 Closed
Citadel Advisors
303
Citadel Advisors
Florida
– -$438K -4,679 Closed
Simplex Trading
304
Simplex Trading
Illinois
– -$410K -4,378 Closed
BHCM
305
Brevan Howard Capital Management
Jersey
– -$307K -3,228 Closed
TI
306
Tidal Investments
Wisconsin
– -$285K -2,993 Closed
MIIM
307
Mesirow Institutional Investment Management
Illinois
– -$270K -2,844 Closed
CAPTRUST Financial Advisors
308
CAPTRUST Financial Advisors
North Carolina
– -$268K -2,819 Closed
Group One Trading
309
Group One Trading
Illinois
– -$235K -2,512 Closed
GCP
310
GSA Capital Partners
United Kingdom
– -$210K -2,214 Closed
ASN
311
Advisory Services Network
Georgia
– -$45.2K -476 Closed
TVAMP
312
Tennessee Valley Asset Management Partners
Tennessee
– -$14.3K -150 Closed
CTWM
313
Cherry Tree Wealth Management
Minnesota
– -$3.61K -38 Closed
TCWA
314
Turtle Creek Wealth Advisors
Texas
– -$3.23K -34 Closed
IA
315
IFP Advisors
Florida
– -$2.66K -28 Closed
GWS
316
Glassman Wealth Services
Virginia
– -$2.19K -23 Closed
BCMLT
317
Beacon Capital Management LLC (Tennessee)
Tennessee
– -$1.87K -20 Closed
CWC
318
Carolinas Wealth Consulting
North Carolina
– -$905 -10 Closed
AF
319
Advisornet Financial
Minnesota
– -$665 -7 Closed
9 10 11 12
13

AMED Hedge Fund Activity: Q1 2024 in Review

283 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2024, worth a combined $2.86B — down 5.4% from $3.02B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of AMED and 33 opened new positions — a net loss of 3 holders — while 114 trimmed existing stakes and 87 added.

The largest buyer was Farallon Capital Management, adding an estimated $30.2M. The largest seller was Vaughan Nelson Investment Management, exiting entirely with an estimated $27.2M sold.

  • 283 institutional investors held Amedisys (AMED) as of Q1 2024, down from 287 in Q4 2023.
  • Funds reported $2.86B of Amedisys stock for Q1 2024, down 5.4% quarter-over-quarter.
  • 33 funds opened new Amedisys positions in Q1 2024 and 36 closed out, a net change of -3 holders.
  • The largest Amedisys buyer in Q1 2024 was Farallon Capital Management, an estimated $30.2M added.
  • The largest Amedisys seller in Q1 2024 was Vaughan Nelson Investment Management, an estimated $27.2M sold.

Based on aggregated 13F filings for Q1 2024.